Skip to main content
OpenTrials

Clinical trial condition

Lugano Classification Stage III Hodgkin Lymphoma AJCC v8

Explore clinical trials studying Lugano Classification Stage III Hodgkin Lymphoma AJCC v8. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 trial results

Recruiting

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

NCT06745076

Conditions
Advanced Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8, +1 more
Locations
  • City of Hope Irvine, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma

NCT00654732

Conditions
Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8, Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
Locations
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions